the present invention provides optimized transfection reagents comprising mixtures of cationiclipoids . in particular , the present invention provides dna delivery vehicles based on identifying the optimal hydrophobicity of novel cationic phospholipid derivatives that , alone or in combination , form complexes with dna and exhibit enhanced transfection activity .